While ERBB3 can potentially dimerize with all members of the ERBB family, several lines of evidence show that the strongest dimer to activate survival pathways like AKT in breast cancer is the ERBB3/ERBB2 dimer [4–7]. This evidence concerns the gene ERBB2 and breast carcinoma.